ENTERO THERAPEUTICS INC (ENTO) Stock Cash Flow
NASDAQ:ENTO • US33749P5070
Current stock price
2.99 USD
+0.15 (+5.28%)
At close:
3.2 USD
+0.21 (+7.02%)
After Hours:
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -17.08M | -18.06M | -15.79M | -58.54M | |||
| Depreciation Amortization | N/A | 49.00K | 29.30K | 542.30K | |||
| Change In Working Capital | 3.19M | 2.53M | 2.19M | 17.10M | |||
| Interest Paid | 16.20K | 36.20K | 22.50K | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 390.40K | 6.26M | 1.20M | 8.61M | |||
| OPERATING CASH FLOW | -2.89M | -9.22M | -12.38M | -32.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | N/A | N/A | N/A | -69.50K | |||
| Other Investing Activity | N/A | 88.20K | -500.00K | -10.25M | |||
| INVESTING CASH FLOW | N/A | 88.20K | -500.00K | -10.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | 495.40K | -644.60K | -603.50K | 88.80K | |||
| Stock Issued/Repurchased | N/A | 6.23M | 15.83M | 44.67M | |||
| FINANCING CASH FLOW | 2.22M | 5.58M | 15.23M | 44.76M | |||
| Exchange Rate Effect | N/A | N/A | N/A | 30.80K | |||
| CHANGE IN CASH | -671.80K | -3.55M | 2.35M | 2.19M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -2.89M | -9.22M | -12.38M | -32.29M | |||
| Capital Expenditure | N/A | N/A | N/A | -69.50K | |||
| FREE CASH FLOW | -2.89M | -9.22M | -12.38M | -32.36M | |||
All data in USD